Abeona Therapeutics Inc. (ABEO) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, everyone, and welcome to Abeona Therapeutics 2Q twenty twenty six Conference Call. At this time, all participants have been placed on a listen only mode and a question and answer session will follow the formal presentation. Please note this conference is I will now turn the conference over to your host, Gregory Jin, Vice President, Investor Relations and Corporate Development. Greg, the floor is yours. Thank you, Jenny. Good morning, and thank you, everyone, for joining us on our second quarter twenty twenty six results conference call. During this call, we will refer to the press release issued this morning announcing the financial results. It's available on our corporate website at www.abionatherapeutics.com. Joining me on today's call are Doctor. Vish Deshagari, Chief Executive Officer Doctor. Madhav Visandavada, Chief Commercial Officer Gil Vasanto, Chief Financial Officer and Doctor. Brian Keveney, Chief Technical Officer. We anticipate making projections and forward looking statements during today's call, which are made pursuant to the Safe Harbor provisions of the federal securities laws. These forward looking statements are based on current expectations and are subject to change. Actual results may differ materially from those expressed or implied in the forward looking statements due to various factors, including, but not limited to, those outlined in our Form 10 ks and periodic reports filed with the Securities and Exchange Commission. These documents are available on our website at www.abontherapeutics.com. And with that, I will now turn the call over to Nish Desairee to leave soft. Vish? Thank you, Greg, and good morning, everyone. I'll begin today with an overview of our commercial progress before turning the call over to Madhav for operati...